Dr. Tonkens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3131 RDU Drive
Suite 100
Morrisville, NC 27560Phone+1 919-308-5216Fax+1 919-573-0882- Is this information wrong?
Summary
- Director of AMERICAN HEART ASSOCIATION Science & Technology Accelerator, focused on identifying the most revolutionary, transformational, game-changing technologies and propelling them from bench to bedside where they can make the greatest positive impact on outcomes through prevention and treatment of cardiovascular disease.
Education & Training
- Yale School of MedicineClass of 1974
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic
- Cedars-Sinai Medical CenterInternship, Surgery
- Cedars-Sinai Medical CenterResidency, Internal Medicine
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease
- Yale CollegeB.A, Psychology
Certifications & Licensure
- NV State Medical License 1990 - 2019
- CA State Medical License 1975 - 2018
Publications & Presentations
PubMed
- 68 citationsFirst Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary InterventionMauricio G. Cohen, Drew A. Purdy, Joseph S. Rossi, Liliana Grinfeld, Shelley K. Myles, Laura H. Aberle, Adam Greenbaum, Edward T.A. Fry, Mark Y. Chan, Ross M. Tonkens,...> ;Circulation. 2010 Aug 10
- 110 citationsPhase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery diseaseMark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James S Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleima...> ;Circulation. 2008 Jun 3
- 76 citationsA randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitorMark Y. Chan, Christopher P. Rusconi, John H. Alexander, Ross M. Tonkens, Robert A. Harrington, Richard C. Becker> ;Journal of Thrombosis and Haemostasis. 2008 May 1
- Join now to see all
Journal Articles
- The Arguments for Maintaining Professional Licensure While Working in Industry.Huml, R., Tonkens, R, Regulatory Focus, pp. 48-50
- CMC, Preclinical and Clinical Considerations for Biosimilars and Follow-on Biologics.Huml, R., Hicks, P., Chance, K., Howe, K., Tonkens, R, Regulatory Affairs Focus, pp. 20-27
- Follow-on Biologics in the EU & US.Huml, R., Chance, K., Howe, K., Hicks, P., Tonkens, R, Regulatory Affairs Focus, pp. 8-13
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A First-in-Class Oligonucleotide Drug-Antidote Pair Efficiently Modulates Factor IXa Activity in Human Subjects - A Nascent Platform for Antidote-Controlled Periproced...Chan, M Y, Cohen, M G, Rusconi, C P, Alexander, J H, Tonkens, R M, Harrington, R C, Becker, R C, et al, American Heart Association Annual Scientific Session
- Antidote-Controlled Modulation of Factor IXa Activity with the First-in-Class REG1Anticoagulation System: A Randomized Phase 1 Repeat Dose Safety and Antidote Dose-Esc...Chan, M Y, Cohen, M G, Rusconi, C P, Tonkens R M, Harrington, R C, Becker, R C, American Heart Association Annual Scientific Session
- Abstract 1555: Antidote-Controlled Modulation of Factor IXa Activity with the First-in- Class REG1 Anticoagulation System: A Randomized Phase 1 Repeat Dose S...Chan, Mark Y., Alexander, John H., Rusconi, Christopher P., Tonkens, Ross M., Harrington, Robert A., Becker, Richard C, Circulation; 116:II_323
- Join now to see all
Other
- Careers in Pharmaceutical Medicine.Tonkens, R, Web Lecture
http://www.acpe.org/toolkit/
American College of Physician Executives
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: